DFW Capital Partners successfully exits its investment in Copernicus Group IRB

DFW Capital Partners announced today that it has completed the sale of its portfolio company, Vigilant Safety Group, which includes its operating subsidiary Copernicus Group IRB, to an affiliate of Arsenal Capital. DFW originally invested in Raleigh, NC-based Vigilant in 2008, supporting a control recapitalization of the company. In connection with its investment, DFW teamed… Read more »

DFW Capital Partners adds Douglas H. Gilbert as a General Partner

DFW Capital Partners announced today that Douglas H. Gilbert has joined the firm as a General Partner, and will be based in the firm’s Washington, D.C. office. Doug comes to DFW with an extensive 20 year background in private equity and debt investing.  For five years prior to joining DFW, Doug was a Managing Director… Read more »

DFW Capital Partners Expands Investment Team

DFW Capital Partners announced today that DeVer F. Warner has joined the firm as an Associate, based in the Teaneck, NJ office. DeVer brings to DFW an existing background in growth capital and private equity investing. A recent MBA from the University of Virginia’s Darden School of Management, DeVer previously worked as an analyst with… Read more »

Venio Acquires Assets of The Keane Organization

DFW Capital Partners announced today that its portfolio company, Venio, has completed the acquisition of the Unclaimed Property and Investor Communications and Retention divisions of The Keane Organization. The combined business will be renamed Keane, an industry brand in existence for over 60 years. Keane is the largest provider of lost shareholder and lost account… Read more »

DFW Capital Partners successfully exits its investment in Alaven Pharmaceutical

October 1, 2010, Teaneck, NJ DFW Capital Partners announced today that it has completed the sale of its portfolio company, ALVP Holdings, which includes operating subsidiaries Alaven Pharmaceuticals and Alaven Consumer Healthcare, to Swedish specialty pharmaceutical company Meda AB. Meda acquired Alaven for an aggregate cash purchase price of $350 million, resulting in a realized… Read more »

DFW Invests in Meta Pharmaceutical Services

DFW Capital Partners announced today that it has closed the recapitalization of Meta Pharmaceutical Services, a leading outsourced service provider to the pharmaceutical industry. DFW invested preferred equity, and raised senior and subordinated debt financing, to facilitate a liquidity event for Meta’s founders, while leaving the core operating team with a significant remaining equity stake.… Read more »